VESILUTE INJECTOR PEN 3ML

Vesilute (Lys-Glu-Asp / KED): The Dual-Target Immune-Urogenital Bioregulator for Bladder, Prostate, Renal, and Mucosal Tissue Restoration — Now Available in the UAE

The vesilute, identified by the scientific name lys-glu-asp (ked) as the three-peptide lys-glu-asp, was created from a study conducted by Dr. Vladimir khavinson and his associates. The peptide has been developed to have the ability to enter the urogenital system and attach itself to cells such as those found within the bladder, kidney, prostate gland, etc., which are targeted by vesilute.

In addition, the vesilute enters into the cell nucleus and binds to certain sequences of dna that when bound can alter the way the genes express themselves. In turn, altered gene expression may reactivate genes responsible for controlling cellular differentiation, proliferation, anti-inflammatory response and restoring barrier function. These functions typically become reduced with age or due to an increase in chronic inflammation and/or metabolic stress. Therefore, the use of vesilute will assist in restorative processes and restore the normal functioning of all components of the urogenital system as well as modulate localized immune responses.

Therefore, because of its unique properties, vesilute has value as a tool for researchers who are studying urogenital disorders caused by immune mediated dysfunction; chronic cystitis; interstitial cystitis; benign prostatic hyperplasia (bhp); overactive bladder (oab); urinary decline related to aging; prostatitis; renal epithelial health; and the interaction between local immune systems and tissue homeostasis within the genitourinary tract. Additionally, due to its ability to reduce levels of inflammatory mediators; support barrier function of epithelial cells; and promote balanced cellular turnover rates; vesilute is positioned at the forefront of research concerning regenerative urology and geroprotection.

Below, explore six key research-supported potential benefits of Vesilute, drawn from mechanistic preclinical data, Khavinson bioregulator science, and related clinical observations.

1. Regulation of the Immune-Urogenital Axis and Localized Inflammation Control
Vesilute has shown specific modulation of immune cell invasion and cytokine production within urogenital tissue with no apparent suppression of systemic immunity; it promotes normal homeostatic balance of urogenital tissue. Vesilute also appears to help restore a healthy ratio of T-cells as well as reduce low-grade persistent inflammation which is likely causing the majority of the damage (tissue) in the bladder, prostate and kidney. Data from preclinical models of chronic non-aseptic inflammation shows decreased levels of edema, reduced level of hyperemia and modulated cellular infiltration suggesting that vesilute allows for an appropriate amount of immune surveillance while reducing damage by excessive inflammatory response.

2. Restoration of Bladder Function, Capacity, and Urothelial Integrity
Vesilute enhances gene expression in both detrusor smooth muscle fiber and urothelium. These enhancements allow for improved bladder compliance, volume, and urothelial barrier. Vesilute has been shown to improve clinical measurements of cystometry such as; higher maximum cystometric capacity (i.e. 20%+ increase) lower diurnal frequency of voiding, less nocturia and an overall decrease in frequency and severity of sudden urge incontinence.

3. Normalization of Prostate Tissue Architecture and Proliferative Balance
The vesilute peptide has been shown to influence gene expression in both prostate epithelial and stromal cells which are important for maintaining proper organization of healthy tissues as well as to help regulate excessive growth or other abnormality of diseased tissues. In addition to promoting normal cellular proliferation by reducing markers of proliferative activity, it is believed that vesilute also promotes better blood circulation through its beneficial effects on vascular structure; thus contributing to overall structural integrity of the prostate.

Experimental studies utilizing animal models of BPH (Benign Prostatic Hyperplasia) and prostatitis demonstrated that Glu-Asp sequences in the vesilute peptide resulted in significantly less prostate size compared to controls; a significant reduction in the total area of epithelial acini; and a decrease in the level of inflammatory cell infiltration into the prostate gland. These results suggest a potential new target for treatment development with respect to BPH and other aspects of male reproductive tract health.

4. Enhancement of Renal Epithelial Protection and Immune Surveillance
The protective effects of Vesilute strengthen local immune defenses within renal tissue; suppress excessive inflammatory and fibrotic signals that cause damage to renal tissue; protect glomerular and tubular epithelial cells from injury; preserve filtration capacity through reduction in immune complex deposition during periods of stress.
The cyto-protective properties of Vesilute are ideal for use in studies involving chronic kidney disease, recurrent urinary tract infections (UTIs), autoimmune diseases affecting the kidneys and/or other forms of declining renal function associated with aging.

5. Mitigation of Age-Related Urogenital Decline and Senescence
The use of Vesilute to combat epigenetically silenced genes that are associated with aging is a method of combating epigenetic silencing of genes associated with aging in urogenital epithelial cells. The treatment helps restore pathways for cell rejuvenation, free radical defenses, and the ability of tissues to recover from stress.
Additionally, longitudinal studies on preclinical models demonstrated that urogenital function was maintained at higher levels than untreated control groups; fewer age-related complications occurred in treated older animal models when compared to untreated animal models; and the histological appearance of treated tissue samples appeared more normal than those of the corresponding tissue samples in controls.

6. Support for Overall Urogenital Homeostasis and Tissue Repair
Beyond individual organ systems, Vesilute stimulates the body’s capacity to heal damaged areas of the urogenital tract in a synchronized manner through improvements in tight junction protein expression, regulation of smooth muscle contraction/relaxation, and maintenance of blood flow at the level of the micro-circulatory network. The resolution of chronic inflammation is facilitated as well as enhanced tissue regeneration during the healing process after an injury/infection. Therefore, its ability to function in an integrated fashion to stimulate healing throughout the entire urogenital system (male/female) makes it a good candidate for future research investigating the inter-relationship of the immune system, the genito-urinary microbiome and/or post-infectious recovery.

Why Choose Our Vesilute Injector Pen?

Our Vesilute comes from trusted manufacturers that have experience in the production of peptides as per Khavinson’s method. Our products also go through stringent quality control tests to verify our product’s purity, potency, identity, sterility, and stability. We test every batch of our products against these high standards in order to produce reproducible results when performing sensitive urogenital and immunological studies.

The precision engineered injection pen design allows for easy subcutaneous injections, precise dosage control, minimizes waste, and has an extended shelf life (storage) for this type of product. The injection pen design we use lends itself well to performing daily or cyclic dose protocols consistently in both laboratory and investigative environments.

Vesilute captures the precision and tissue specificity of the Bioregulators developed by Dr. Khavinson. By being targeted toward two main systems; Immune and Uro-genital Systems, it provides scientists with a powerful Epigenetic Tool to study Regeneration Pathways within Bladder, Prostate, and Renal Health — which are all of great Clinical Interest and Scientific Study.

Please always refer to your Healthcare Provider or Research Ethics Committee/Institutional Review Board prior to beginning any Protocol. All statements regarding our Products are made from Scientific Literature and are made available to you for Informational/Educational Purposes Only. No statement contained herein should be used to Diagnose, Treat Cure or Prevent any Disease.

Important Note: This product is intended strictly for research and laboratory use only. It is not for personal consumption, human or animal therapeutic use, or any clinical application. Please consult and fully comply with all local regulations in the UAE before purchasing or handling.